PDI
PDI产品
- 所有产品(4)
- PDI抑制剂 (4)
| 目录号 | 产品名 | 产品描述 | 文献引用 | 实验数据 |
|---|---|---|---|---|
| S8281 | CCF642 | CCF642 (AC1LYELL)是一种新型的蛋白质二硫键异构酶（PDI）抑制剂，具有抗骨髓瘤活性。 | ||
| S0321 | LOC14 | LOC14 是一种有效的 protein disulfide isomerase (PDI) 的抑制剂，EC50值为500 nM和Kd值为62 nM。 | ||
| S2846 | ML359 | ML359 是一种 protein disulfide isomerase (PDI) 的小分子抑制剂。 | ||
| E6697New | PACMA 31 | PACMA 31 is an irreversible, orally active inhibitor of protein disulfide isomerase (PDI) with an IC50 of 10 μM. It covalently binds PDI's active-site cysteines, inhibiting reductase/isomerase activity in a dose- and time-dependent manner per insulin aggregation assays. | ||
| S8281 | CCF642 | CCF642 (AC1LYELL)是一种新型的蛋白质二硫键异构酶（PDI）抑制剂，具有抗骨髓瘤活性。 | ||
| S0321 | LOC14 | LOC14 是一种有效的 protein disulfide isomerase (PDI) 的抑制剂，EC50值为500 nM和Kd值为62 nM。 | ||
| S2846 | ML359 | ML359 是一种 protein disulfide isomerase (PDI) 的小分子抑制剂。 | ||
| E6697New | PACMA 31 | PACMA 31 is an irreversible, orally active inhibitor of protein disulfide isomerase (PDI) with an IC50 of 10 μM. It covalently binds PDI's active-site cysteines, inhibiting reductase/isomerase activity in a dose- and time-dependent manner per insulin aggregation assays. | ||
| E6697New | PACMA 31 | PACMA 31 is an irreversible, orally active inhibitor of protein disulfide isomerase (PDI) with an IC50 of 10 μM. It covalently binds PDI's active-site cysteines, inhibiting reductase/isomerase activity in a dose- and time-dependent manner per insulin aggregation assays. |
